Cross-institution positioning
Jul 30, 2026Mixed positioning. 1 accumulating, 1 exited across 2 comparable institutions.
Source: Schedule 13 researchCALIX, INC
Latest stored close $37.24 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. 1 accumulating, 1 exited across 2 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/53 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +21.3% YoY; Net income +8,698.5% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 4% through its reported 52-week range; -42.4% over one year.
Source: Stored historical price seriesFiled Jul 30, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | Russo Carl | AGrant, award, or other acquisition · derivative | Stock Options (right to buy) | 17.6K | $0.00 | Direct | Sep 29, 2026 |
| Jul 27, 2026 | Russo Carl | SOpen-market or private sale | Common Stock | 75.0K | $36.20 | Indirect | Jul 28, 2026 |
| Jun 29, 2026 | Russo Carl | AGrant, award, or other acquisition · derivative | Stock Options (right to buy) | 16.0K | $0.00 | Direct | Jun 30, 2026 |
| May 14, 2026 | BOWICK CHRISTOPHER J | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | BERRY MICHAEL J | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | Mukherjee Rajatish | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | Oosterman Wade | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | Peters Kevin Robert | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | CRUSCO KATHLEEN M | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | Russo Carl | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| May 14, 2026 | Makagon Kira | AGrant, award, or other acquisition | Common Stock | 5.0K | $0.00 | Direct | May 18, 2026 |
| Apr 27, 2026 | Russo Carl | SOpen-market or private sale | Common Stock | 4.1K | $43.75 | Indirect | Apr 28, 2026 |
| Apr 27, 2026 | Russo Carl | SOpen-market or private sale | Common Stock | 20.9K | $43.17 | Indirect | Apr 28, 2026 |
| Apr 8, 2026 | Russo Carl | GGift | Common Stock | 40.0K | $0.00 | Direct | Apr 10, 2026 |
| Feb 1, 2022 | Peters Kevin Robert | GGift | Common Stock | 126.0K | $0.00 | Indirect | May 18, 2026 |
| Feb 1, 2022 | Peters Kevin Robert | GGift | Common Stock | 126.0K | $0.00 | Direct | May 18, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 8, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jul 21, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jul 20, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 15, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Apr 21, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 21, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Jan 28, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jan 28, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Nov 17, 2025 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Oct 29, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 27, 2026 | $293.3M | +21.3% |
| Ended Mar 28, 2026 | $280.0M | +27.1% |
| Ended Sep 27, 2025 | $265.4M | +32.1% |
| Ended Jun 28, 2025 | $241.9M | +22.1% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $1.0B | +20.3% |
| Ended Dec 31, 2024 | $831.5M | -20.0% |
| Ended Dec 31, 2023 | $1.0B | +19.8% |
| Ended Dec 31, 2022 | $867.8M | +27.7% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 30, 2026 filed · 30d Schedule 13G amendment | Reported accumulation | 10.3M +652.5K | 16.20% +1.30 pts | $37.32 | $35.18 | $37.24 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -8.6M | 0.00% -13.29 pts | $50.57 | $51.02 | $37.24 |
| Vanguard Group CIK0000102909 | Jun 30, 2025 observed Jul 29, 2025 filed · 29d Schedule 13G amendment | Reported accumulation | 8.6M +1.1M | 13.29% +1.80 pts | $53.19 | $56.20 | $37.24 |
Compare CALX with other securities showing similar institutional activity or recent accumulation across several tracked institutions.